Clinical Trials Logo

Crizotinib clinical trials

View clinical trials related to Crizotinib.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03718117 Completed - NSCLC Clinical Trials

Descriptive Observational Study ALK-2016-CPHG

ALK2016CPHG
Start date: January 3, 2017
Phase:
Study type: Observational [Patient Registry]

Descriptive Observational Study. Characteristics Of ALK-positive and ROS1-positive Adults Patients Non-Small Cell Lung Cancer (NSCLC) Treated With Crizotinib Within General Hospitals

NCT ID: NCT01945021 Completed - Clinical trials for Non Small Cell Lung Cancer

Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC

Start date: September 30, 2013
Phase: Phase 2
Study type: Interventional

To assess treatment effectiveness and safety of oral crizotinib administered to East Asian patients with Advanced Non-Small Cell Lung Cancer (NSCLC) that is confirmed to be positive for a ROS1 positive gene mutation (translocation or inversion) and confirmed negative for an ALK mutation